SCHEMBL5658446

SCHEMBL5658446

COc1ccc(N2C(=O)C(c3cc(C)c(O)c(C)c3)(c3cc(C)c(O)c(C)c3)c3ccccc32)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.39
LMNA P02545 1/20 0.39
CYP2C9 P11712 1/20 0.38
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
MAPK1 P28482 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CNR1 P21554 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
GAA P10253 2/20 0.36
ALOX5 P09917 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
ALDH1A1 P00352 1/20 0.36
G6PD P11413 1/20 0.35
TLR9 Q9NR96 1/20 0.35
BRD9 Q9H8M2 1/20 0.35
MAPT P10636 1/20 0.35
NR1H3 Q13133 2/20 0.35
NR1H2 P55055 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659431 0.86 PGR (0.44) SCN9ALMNAPOLBKDM4ECNR1
SCHEMBL5656443 0.85 MAPT (0.44) SCN9AKDM4ECNR1GPR55GAA
SCHEMBL5659374 0.83 PGR (0.42) LMNACYP2C9CNR1GPR55ALOX5
SCHEMBL5661596 0.83 CNR1 (0.42) LMNACYP2C9MAPK1CNR1GPR55
SCHEMBL30929657 0.83 CNR1 (0.42) LMNACYP2C9MAPK1CNR1GPR55
SCHEMBL5662112 0.83 MAPT (0.41) SCN9ATP53POLBKDM4ECNR1
SCHEMBL5656731 0.82 MAPT (0.41) SCN9ALMNATP53KDM4ECNR1
SCHEMBL5661100 0.82 MAPT (0.41) SCN9ATP53KDM4ECNR1GPR55
SCHEMBL5662233 0.81 HSP90AA1 (0.41) LMNATP53CNR1GPR55GAA
SCHEMBL5658916 0.81 MAPT (0.40) SCN9AKDM4ECNR1GPR55GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 SCN9A 1918/4885LMNA 3323/4885CYP2C9 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.